ReviewAmerican journal of blood research2025

Chimeric antigen receptor modified T cells directed against CD19 (CTL019) in patients with relapsed, refractory CLL: a systematic review and meta-analysis.

Mohammad Amin Karimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.